1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Nadezhdin, K.D.
Bocharova, O.V.
Bocharov, E.V.
Arseniev, A.S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
RU
Acta Naturae
2075-8251
3
69
76
22649674
Structural and dynamic study of the transmembrane domain of the amyloid precursor protein.
2011
10.2210/pdb2llm/pdb
pdb_00002llm
4450.460
Amyloid beta A4 protein
UNP residues 686-726
1
man
polymer
ABPP, APPI, APP, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-II, N-APP, Soluble APP-alpha, S-APP-alpha, Soluble APP-beta, S-APP-beta, C99, Beta-amyloid protein 42, Beta-APP42, Beta-amyloid protein 40, Beta-APP40, C83, P3(42), P3(40), C80
no
no
GSQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKK
GSQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
APP, A4, AD1
9606
Homo sapiens
562
Escherichia coli
pGEMEX-1
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_nmr_spectrometer
struct_ref_seq_dif
repository
Initial release
Data collection
Database references
Other
1
0
2012-06-20
1
1
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
BMRB
Y
RCSB
2011-11-15
REL
REL
REL
REL
structures with the least restraint violations
20
20
2D 1H-15N HSQC
2D 1H-13C HSQC
3D HNCO
3D HNCA
3D HN(CO)CA
3D HCCH-TOCSY
3D 1H-13C NOESY aliphatic
2D 1H-15N HSQC
3D 1H-15N NOESY
3D 1H-15N TOCSY
0.3-1
mM
[U-100% 13C; U-100% 15N]
21-70
mM
[U-100% 2H]
0.3-1
mM
[U-100% 15N]
21-70
mM
20
4.6
ambient
318
K
simulated annealing
1
fewest violations
0.3-1 mM [U-100% 13C; U-100% 15N] APPjmtm, 21-70 mM [U-100% 2H] DPC, 95% H2O/5% D2O
95% H2O/5% D2O
0.3-1 mM [U-100% 15N] APPjmtm, 21-70 mM DPC, 95% H2O/5% D2O
95% H2O/5% D2O
Bruker Biospin
collection
TopSpin
Bruker Biospin
processing
TopSpin
Guntert, Mumenthaler and Wuthrich
structure solution
CYANA
2.1
Guntert, Mumenthaler and Wuthrich
refinement
CYANA
2.1
Koradi, Billeter and Wuthrich
geometry optimization
MOLMOL
Koradi, Billeter and Wuthrich
visualization
MOLMOL
Cornilescu, Delaglio and Bax
refinement
TALOS+
Cornilescu, Delaglio and Bax
structure solution
TALOS+
R.L.J.Keller
chemical shift assignment
CARA
R.L.J.Keller
data analysis
CARA
R.L.J.Keller
peak picking
CARA
600
Bruker
AVANCE
Bruker Avance
800
Bruker
AVANCE
Bruker Avance
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
GLN
3
n
3
GLN
3
A
LYS
4
n
4
LYS
4
A
LEU
5
n
5
LEU
5
A
VAL
6
n
6
VAL
6
A
PHE
7
n
7
PHE
7
A
PHE
8
n
8
PHE
8
A
ALA
9
n
9
ALA
9
A
GLU
10
n
10
GLU
10
A
ASP
11
n
11
ASP
11
A
VAL
12
n
12
VAL
12
A
GLY
13
n
13
GLY
13
A
SER
14
n
14
SER
14
A
ASN
15
n
15
ASN
15
A
LYS
16
n
16
LYS
16
A
GLY
17
n
17
GLY
17
A
ALA
18
n
18
ALA
18
A
ILE
19
n
19
ILE
19
A
ILE
20
n
20
ILE
20
A
GLY
21
n
21
GLY
21
A
LEU
22
n
22
LEU
22
A
MET
23
n
23
MET
23
A
VAL
24
n
24
VAL
24
A
GLY
25
n
25
GLY
25
A
GLY
26
n
26
GLY
26
A
VAL
27
n
27
VAL
27
A
VAL
28
n
28
VAL
28
A
ILE
29
n
29
ILE
29
A
ALA
30
n
30
ALA
30
A
THR
31
n
31
THR
31
A
VAL
32
n
32
VAL
32
A
ILE
33
n
33
ILE
33
A
VAL
34
n
34
VAL
34
A
ILE
35
n
35
ILE
35
A
THR
36
n
36
THR
36
A
LEU
37
n
37
LEU
37
A
VAL
38
n
38
VAL
38
A
MET
39
n
39
MET
39
A
LEU
40
n
40
LEU
40
A
LYS
41
n
41
LYS
41
A
LYS
42
n
42
LYS
42
A
LYS
43
n
43
LYS
43
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
SER
14
-159.28
74.61
1
A
LYS
42
56.67
88.13
2
A
VAL
12
-126.67
-72.38
2
A
SER
14
-161.99
42.39
2
A
ASN
15
-172.99
97.07
3
A
SER
2
-130.96
-71.63
3
A
LYS
4
-124.59
-50.27
3
A
SER
14
-154.89
-68.38
3
A
ASN
15
-122.52
-65.87
3
A
LYS
16
-165.31
-74.42
3
A
LYS
42
-172.47
130.83
5
A
GLN
3
-113.32
55.37
5
A
VAL
12
-134.74
-65.27
6
A
GLN
3
-172.10
57.47
6
A
LYS
4
-133.82
-49.05
6
A
SER
14
-54.95
-74.12
6
A
ASN
15
-162.04
27.94
7
A
SER
2
58.70
79.50
7
A
GLN
3
-145.10
32.89
7
A
SER
14
-162.41
-74.28
7
A
ASN
15
-150.89
-75.05
7
A
LYS
16
-143.71
-74.21
8
A
GLN
3
-96.91
49.04
8
A
LYS
42
-58.53
-178.84
9
A
SER
14
-175.37
82.86
9
A
ASN
15
-152.02
-68.42
9
A
LYS
16
-147.88
-74.30
10
A
GLN
3
-150.50
42.16
10
A
SER
14
-108.29
41.50
10
A
ASN
15
59.26
77.41
10
A
LYS
42
-170.50
-55.41
11
A
LYS
41
60.73
96.90
12
A
GLN
3
-174.93
52.34
12
A
VAL
12
-151.93
76.34
12
A
SER
14
-147.36
-67.39
12
A
LYS
16
71.57
-69.54
13
A
LYS
16
69.01
-75.73
13
A
LYS
41
-65.85
-73.98
13
A
LYS
42
59.01
177.77
14
A
GLN
3
-142.74
33.73
14
A
SER
14
-160.12
71.09
14
A
ASN
15
-126.76
-68.33
14
A
LYS
16
-143.91
-74.46
15
A
GLN
3
-156.98
30.02
15
A
VAL
12
-91.91
-68.60
15
A
SER
14
56.51
86.41
15
A
ASN
15
-169.70
85.57
15
A
LYS
16
-87.39
-73.51
15
A
LYS
41
61.79
96.78
15
A
LYS
42
-94.50
-68.94
16
A
SER
14
-179.38
97.56
16
A
ASN
15
-116.28
-76.50
16
A
LYS
16
-153.07
-75.44
16
A
LYS
42
-68.12
89.33
17
A
ASN
15
-175.02
98.69
18
A
VAL
12
-92.40
-60.27
18
A
ASN
15
-164.17
79.65
18
A
LYS
42
-66.64
-169.78
19
A
SER
14
-174.77
95.11
19
A
ASN
15
-175.92
99.46
19
A
LYS
42
-168.81
-65.70
20
A
LYS
16
70.70
-70.21
20
A
LYS
42
-143.46
-45.13
fewest violations, model 1
Structure of amyloid precursor protein's transmembrane domain
1
N
N
A
LYS
4
A
LYS
4
HELX_P
A
VAL
12
A
VAL
12
1
1
9
A
ASN
15
A
ASN
15
HELX_P
A
LYS
42
A
LYS
42
1
2
28
PROTEIN FIBRIL
Alzheimer's disease, PROTEIN FIBRIL
A4_HUMAN
UNP
1
686
P05067
QKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKK
686
726
2LLM
3
43
P05067
A
1
3
43
1
expression tag
GLY
1
2LLM
A
P05067
UNP
1
1
expression tag
SER
2
2LLM
A
P05067
UNP
2